<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medicina Regenerativa &#187; Publicaciones internacionales</title>
	<atom:link href="https://temas.sld.cu/medicinaregenerativa/category/publicaciones-internacionales/feed/" rel="self" type="application/rss+xml" />
	<link>https://temas.sld.cu/medicinaregenerativa</link>
	<description>Sitio de la red de salud de Cuba sobre Medicina Regenerativa</description>
	<lastBuildDate>Wed, 06 Dec 2023 04:32:56 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Intra-Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof-of-Concept Clinical Trial   CH Jo</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2016/08/23/intra-articular-injection-of-mesenchymal-stem-cells-for-the-treatment-of-osteoarthritis-of-the-knee-a-proof-of-concept-clinical-trial-ch-jo/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2016/08/23/intra-articular-injection-of-mesenchymal-stem-cells-for-the-treatment-of-osteoarthritis-of-the-knee-a-proof-of-concept-clinical-trial-ch-jo/#comments</comments>
		<pubDate>Tue, 23 Aug 2016 13:24:58 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=3257</guid>
		<description><![CDATA[TranTranslational and Clinical Research Authors • Chris Hyunchul Jo, 1. • Young Gil Lee, 1. • Won Hyoung Shin, 1. • Hyang Kim, 1. • Jee Won Chai, 1. • Eui Cheol Jeong, 1. • Ji Eun Kim, 1. • Hackjoon Shim, 1. • Ji Sun Shin, 1. • Il Seob Shin, 1. • Jeong [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2016/08/23/intra-articular-injection-of-mesenchymal-stem-cells-for-the-treatment-of-osteoarthritis-of-the-knee-a-proof-of-concept-clinical-trial-ch-jo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>La investigación con células troncales embrionarias, ejemplo de progreso biotecnológico bajo presiones extracientíficas.</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2014/09/07/la-investigacion-con-celulas-troncales-embrionarias-ejemplo-de-progreso-biotecnologico-bajo-presionesextracientificas-jose-a-gamez-escalonacuadernos-de-bioetica-xxiv-20133a/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2014/09/07/la-investigacion-con-celulas-troncales-embrionarias-ejemplo-de-progreso-biotecnologico-bajo-presionesextracientificas-jose-a-gamez-escalonacuadernos-de-bioetica-xxiv-20133a/#comments</comments>
		<pubDate>Sun, 07 Sep 2014 14:25:59 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=3047</guid>
		<description><![CDATA[THE EMBRYONIC STEM CELLS RESEARCH. EXAMPLE OF BIOTECHNOLOGY PROGRESS UNDER EXTRA-SCIENTIFIC PRESSURE JOSÉ ANTONIO GÁMEZ ESCALONA Universidad Monteávila 1060a Caracas jgamez@uma.edu.ve Fuente:  Gámez Escalona, José A (2013).Cuadernos de Bioética XXIV /3a.]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2014/09/07/la-investigacion-con-celulas-troncales-embrionarias-ejemplo-de-progreso-biotecnologico-bajo-presionesextracientificas-jose-a-gamez-escalonacuadernos-de-bioetica-xxiv-20133a/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advancing regenerative medicine.Nature Medicine 20, 795 (2014)</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2014/09/02/advancing-regenerative-medicinenature-medicine-20-795-2014/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2014/09/02/advancing-regenerative-medicinenature-medicine-20-795-2014/#comments</comments>
		<pubDate>Tue, 02 Sep 2014 16:27:20 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=3041</guid>
		<description><![CDATA[NATURE MEDICINE &#124; EDITORIAL doi:10.1038/nm.3658 Regenerative medicine may enable replacement of damaged or diseased tissues. But its clinical success will require deeper understanding of the basic biology of the stem cell niche and coordination between stem cell biologists and those in other fields. It&#8217;s been more than 15 years since the term &#8216;regenerative medicine&#8217; entered [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2014/09/02/advancing-regenerative-medicinenature-medicine-20-795-2014/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells . J . Hematol &amp; Oncol. 2014</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2014/07/30/advances-in-understanding-the-cell-types-and-approaches-used-for-generating-induced-pluripotent-stem-cells-j-hematol-oncol-2014/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2014/07/30/advances-in-understanding-the-cell-types-and-approaches-used-for-generating-induced-pluripotent-stem-cells-j-hematol-oncol-2014/#comments</comments>
		<pubDate>Wed, 30 Jul 2014 14:59:33 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>
		<category><![CDATA[pluripotent stem cells]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=3020</guid>
		<description><![CDATA[Advances in understanding the tissue origin and generation of induced pluripotent stem cells Journal of Hematology &#38; Oncology 2014, 7:50 doi:10.1186/s13045-014-0050-z Jun Li (jlee200201@hotmail.com) Song Wei (SDSLYYSW@163.com) Guangjin Pan (pan_guangjin@gibh.ac.cn) Jun Zhou (zhoujun1202@126.com) Abstract Successfully reprogramming somatic cells to a pluripotent state generates induced pluripotent stem (iPS) cells (or iPSCs), which have extensive self-renewal capacity [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2014/07/30/advances-in-understanding-the-cell-types-and-approaches-used-for-generating-induced-pluripotent-stem-cells-j-hematol-oncol-2014/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database of Systematic Reviews 2014,</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2014/05/07/stem-cell-therapy-for-chronic-ischaemic-heart-disease-and-congestive-heart-failure-cochrane-database-of-systematic-reviews-2014/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2014/05/07/stem-cell-therapy-for-chronic-ischaemic-heart-disease-and-congestive-heart-failure-cochrane-database-of-systematic-reviews-2014/#comments</comments>
		<pubDate>Wed, 07 May 2014 13:46:09 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>
		<category><![CDATA[chronic ischaemic heart disease]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=2937</guid>
		<description><![CDATA[Abstract Background A promising approach to the treatment of chronic ischaemic heart disease (IHD) and heart failure is the use of stem cells. The last decade has seen a plethora of randomised controlled trials (RCTs) developed worldwide which have generated conflicting results. Objectives The critical evaluation of clinical evidence on the safety and efficacy of [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2014/05/07/stem-cell-therapy-for-chronic-ischaemic-heart-disease-and-congestive-heart-failure-cochrane-database-of-systematic-reviews-2014/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A preliminary evaluation of efficacy and safety of Wharton&#8217;s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.April 2014</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2014/04/30/a-preliminary-evaluation-of-efficacy-and-safety-of/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2014/04/30/a-preliminary-evaluation-of-efficacy-and-safety-of/#comments</comments>
		<pubDate>Wed, 30 Apr 2014 14:09:40 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=2914</guid>
		<description><![CDATA[A preliminary evaluation of efficacy and safety of Wharton&#8217;s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus Introduction Stem cell therapy has recently been introduced to treat patients with type 2 diabetes mellitus (T2DM). However, no data are available on the efficacy and safety of allogeneic Wharton’s Jelly-derived mesenchymal stem cell [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2014/04/30/a-preliminary-evaluation-of-efficacy-and-safety-of/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>One year follow up of Intracoronary stem cell delivery on left ventricular function following ST-Elevation Myocardial Infarction</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2013/11/28/one-year-follow-up-of-intracoronary-stem-cell-delivery-on-left-ventricular-function-following-st-elevation-myocardial-infarctiontraverse-jh-et-al-jamanov-18-2013/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2013/11/28/one-year-follow-up-of-intracoronary-stem-cell-delivery-on-left-ventricular-function-following-st-elevation-myocardial-infarctiontraverse-jh-et-al-jamanov-18-2013/#comments</comments>
		<pubDate>Thu, 28 Nov 2013 15:52:58 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=2758</guid>
		<description><![CDATA[Jay H. Traverse, MD1; Timothy D. Henry, MD1; Carl J. Pepine, MD2; James T. Willerson, MD3; Stephen G. Ellis, MD4 JAMA. Published online November 18, 2013. doi:10.1001/jama.2013.282674 http://jama.jamanetwork.com/article.aspx?articleid=178001621 NOV 13 &#124; American Heart Association Scientific Sessions ¿Son útiles las células madre en el infarto agudo del miocardio? La administración de células madre después de una [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2013/11/28/one-year-follow-up-of-intracoronary-stem-cell-delivery-on-left-ventricular-function-following-st-elevation-myocardial-infarctiontraverse-jh-et-al-jamanov-18-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Therapeutic Effects of Human Adipose-Derived Stem Cells in Alzheimer’s Disease Mouse Models.Neurodegener Dis.2013</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2013/11/09/the-therapeutic-effects-of-humanadipose-derived-stem-cells-inalzheimers-disease-mouse-modelsneurodegener-dis2013/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2013/11/09/the-therapeutic-effects-of-humanadipose-derived-stem-cells-inalzheimers-disease-mouse-modelsneurodegener-dis2013/#comments</comments>
		<pubDate>Sat, 09 Nov 2013 15:17:43 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=2743</guid>
		<description><![CDATA[Keun -A. Chang a, Hee Jin Kim b , c ,Yuyoung Joo , Sungji Ha a, Yoo &#8211; Hun Suh b , c . a, Departamento de Farmacología de la Facultad de Medicina de la Universidad Gachon , Incheon, b Departamento de Biomédica, Ciencias de la Facultad de Medicina de la Universidad Nacional de Seúl [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2013/11/09/the-therapeutic-effects-of-humanadipose-derived-stem-cells-inalzheimers-disease-mouse-modelsneurodegener-dis2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mesenchymal stem cells to augment therapeutic angiogenesis in hind-limb ischemia models: how important is their source?Stem Cell Res &amp; Ther 2013,</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2013/10/28/mesenchymal-stem-cells-to-augment-therapeutic-angiogenesis-in-hind-limb-ischemia-models-how-important-is-their-sourcestem-cell-res-ther-2013/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2013/10/28/mesenchymal-stem-cells-to-augment-therapeutic-angiogenesis-in-hind-limb-ischemia-models-how-important-is-their-sourcestem-cell-res-ther-2013/#comments</comments>
		<pubDate>Mon, 28 Oct 2013 14:42:02 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=2723</guid>
		<description><![CDATA[Garry P Duffy* and Caroline C Herron Murine models of hind-limb ischemia are frequently used to assess interventions aimed at improving therapeutic angiogenesis in critical limb ischemia. Much of the current focus of angiogenesis lies with mesenchymal stem cells (MSCs). Important considerations when using these models include the strain of mouse, because some strains recover [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2013/10/28/mesenchymal-stem-cells-to-augment-therapeutic-angiogenesis-in-hind-limb-ischemia-models-how-important-is-their-sourcestem-cell-res-ther-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Priming of mononuclear cells with a combination of growth factors enhances wound healing via high angiogenic and engraftment capabilities.J Cell Mol Med. 2013</title>
		<link>https://temas.sld.cu/medicinaregenerativa/2013/10/16/priming-of-mononuclear-cells-with-a-combination-of-growth-factors-enhances-wound-healing-via-high-angiogenic-and-engraftment-capabilitiesj-cell-mol-med-2013/</link>
		<comments>https://temas.sld.cu/medicinaregenerativa/2013/10/16/priming-of-mononuclear-cells-with-a-combination-of-growth-factors-enhances-wound-healing-via-high-angiogenic-and-engraftment-capabilitiesj-cell-mol-med-2013/#comments</comments>
		<pubDate>Wed, 16 Oct 2013 13:19:21 +0000</pubDate>
		<dc:creator><![CDATA[medicinaregenerativa]]></dc:creator>
				<category><![CDATA[Publicaciones internacionales]]></category>
		<category><![CDATA[estimulación a corto plazo de las CMN con factores de crecimiento]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/medregenerativa/?p=2685</guid>
		<description><![CDATA[Resumen. Recientemente, se ha demostrado que una combinación específica de factores de crecimiento mejora la supervivencia, la adhesión y el potencial angiogénico de las células mononucleares (CMN) . En este estudio, hemos tratado de investigar los cambios en el potencial angiogénico de las CMN después de una preparación de corta duración con una combinación específica [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/medicinaregenerativa/2013/10/16/priming-of-mononuclear-cells-with-a-combination-of-growth-factors-enhances-wound-healing-via-high-angiogenic-and-engraftment-capabilitiesj-cell-mol-med-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
